WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

A REVIEW ON DISTINCTION OF ROSUVASTATIN VS ATORVASTATIN

Ilakkiya G.*, Gunavathisree N. and Kontham Jyothi

ABSTRACT

Statin is also known as an HMG-CoA reductase inhibitor which acts by binding and blocking HMG-CoA reductase (3-hydroxy-3- methylglutaryl coenzyme A reductase) leading to a decrease in bad cholesterol such as low-density lipoprotein, triglyceride, lower total cholesterol and increases good cholesterol i.e., high-density lipoprotein.[1],[2] Whereas HMG-CoA reductase involves in facilitates the conversion of HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) into mevalonate, a pivotal step that involves a four-electron oxidoreduction reaction.[3]

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More